Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
BMC Cancer|October 12, 2010
A profile of prognostic and molecular factors in European and Māori breast cancer patientsGabi U Dachs, Maiko Kano, Ekaterina Volkova, et al.
Frontiers in Oncology|April 14, 2022
Increased Ascorbate Content of Glioblastoma Is Associated With a Suppressed Hypoxic Response and Improved Patient SurvivalEleanor R Burgess, Rebekah L I Crake, Elisabeth Phillips, et al.
Plos One|August 15, 2014
Tumour cells expressing single VEGF isoforms display distinct growth, survival and migration characteristicsChryso Kanthou, Gabi U Dachs, Diane V Lefley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1Kaye J Williams, Brian A Telfer, Dia Xenaki, et al.
Epigenomes|May 28, 2024
Blood Vitamin C Levels of Patients Receiving Immunotherapy and Relationship to Monocyte Subtype and Epigenetic ModificationBen Topham, Millie de Vries, Maria Nonis, et al.
Cancer Research|February 11, 2010
The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3Christopher P Guise, Maria R Abbattista, Rachelle S Singleton, et al.
Scientific Reports|September 1, 2022
Ascorbate content of clinical glioma tissues is related to tumour grade and to global levels of 5-hydroxymethyl cytosineRebekah L I Crake, Eleanor R Burgess, George A R Wiggins, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3Maria R Abbattista, Amir Ashoorzadeh, Christopher P Guise, et al.
Pageof 6